Results 241 to 250 of about 569,644 (316)
Objective The aim of this study was to evaluate the sensitivity of the 2023 American College of Rheumatology (ACR)/EULAR classification criteria for antiphospholipid syndrome (APS) in a real‐world cohort of women diagnosed with primary obstetric APS (oAPS) and to assess their ability to identify patients at risk of future pregnancy complications ...
Francesca Ruffilli +10 more
wiley +1 more source
Growth hormone-releasing hormone in retinal disorders and uveitis: an updated review. [PDF]
Yi SL, Huang YQ.
europepmc +1 more source
People with systemic autoimmune and rheumatic diseases (SARDs) are at higher risk than the general population of experiencing adverse pregnancy and perinatal outcomes such as preeclampsia, intrauterine growth restriction, and maternal and/or fetal death.
Mehret Birru Talabi, Sonya Borrero
wiley +1 more source
Anchoring levonorgestrel-releasing intrauterine system versus suture fixation of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis. [PDF]
Yan H, Gao JH.
europepmc +1 more source
Surpassing genetic height potential at final adult height after monthly depot leuprolide therapy in Taiwanese girls with central precocious or early puberty: a ROC-based analysis. [PDF]
Lin PC, Lai YW, Lo FS.
europepmc +1 more source
ErB4 and NdB4 nanostructured powders are produced by mechanochemical synthesis. 5 h mechanical alloying and 4 M HCl acid leaching are used in the production. ErB4 and NdB4 powders exhibit maximum magnetization of 0.4726 emu g−1 accompanied with an antiferromagnetic‐to‐paramagnetic phase transition at about TN = 18 K and 0.132 emu g−1 with a maximum at ...
Burçak Boztemur +5 more
wiley +1 more source
Hypothalamic regulation of energy homeostasis: Quo vadis. [PDF]
López M, Friedman JM.
europepmc +1 more source

